# Slide Away Phase Execution Summary

- Date: `2026-03-11`
- Status: `completed through Phase 8 with final approval still on hold`

## Phase 0

- standard wrapper interface closed
- script map documented in `reviews/02_execution/01_script_interface_map.md`

## Phase 1

- `case_master.parquet` built
- canonical cases: `413`
- signal-ready cases: `406`

## Phase 2

- `outcomes_v1.parquet` built
- mean outcome quality score: `0.8054`
- intrusion coverage: `329`

## Phase 3

- `features_v1.parquet` and `features_v1_strict_origin.parquet` built
- standard-baseline feature rows: `406`
- cluster-input-ready rows: `398`

## Phase 4

- `window_sweep_summary.csv` built
- current best operating window: `100 ms`
- best `k`: `2`
- silhouette after the `x/y/z` feature refresh: `0.7206`

## Phase 5

- `mode_study_summary.csv` built
- selected mode count: `2`
- cluster split: `392 / 6`
- result remains provisional only

## Phase 6

- `ri_vs_safety_map.csv` and figures built
- current RI vs safety severity correlation: `0.0193`

## Phase 7

- `04_casebooks/01_matched_pair_casebook.md` built
- `04_casebooks/02_structure_strategy_codebook.csv` built
- pair count: `12`

## Phase 8

- `final_study_brief.md` built
- `final_decision_log.md` built
- final approval state remains `hold`

## Post-Phase Blocker Review

- `03_analysis/03_window_candidate_review.md` built
- `03_analysis/04_minor_cluster_review.md` built
- `03_analysis/05_extended_linkage_review.md` built
- `03_analysis/07_domain_outcome_linkage_review.md` built
- `03_analysis/11_preregistered_lower_ext_subgroup_validation.md` built
- `03_analysis/12_mode_confounding_signoff.md` built
- `03_analysis/13_domain_approval_logic_review.md` built
- `03_analysis/14_observation_flavored_naming_review.md` built
- `100 ms` remains the best current candidate, but historic `0-150 ms` is still not retired
- the `6`-case minor cluster remains review-only because confounding is still plausible
- proxy-aware linkage is better than RI alone, but interaction gain is still modest
- domain linkage shows the strongest current signal is on lower-extremity outcomes
- preregistered subgroup validation keeps `passenger` and `2015-2017` lower-ext hints as review evidence, not approval-grade claims
- approval logic now treats pooled severity as summary-only and lower-extremity as the primary review domain
- observation-flavored naming now uses `bulk moderate / unresolved` and `high-lateral review pocket`
- `unittest` coverage now includes feature rules, window selection, and domain join behavior
- smoke result: `11` tests passed
